Parkinson's disease and impaired chemosensitivity to hypoxia.
Kanda
A
A
Ebihara
S
S
Arai
H
H
Takeda
A
A
Sasaki
H
H
D002110:Caffeine / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D012119:Respiration; D013806:Theophylline / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D002110:Caffeine; D013806:Theophylline